Annual CAPEX
$17.92 M
-$3.56 M-16.58%
May 26, 2024
Summary
- As of February 12, 2025, LFCR annual capital expenditures is $17.92 million, with the most recent change of -$3.56 million (-16.58%) on May 26, 2024.
- During the last 3 years, LFCR annual CAPEX has fallen by -$7.30 million (-28.95%).
- LFCR annual CAPEX is now -59.94% below its all-time high of $44.73 million, reached on May 1, 2019.
Performance
LFCR CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CAPEX
$2.47 M
-$922.00 K-27.18%
November 24, 2024
Summary
- As of February 12, 2025, LFCR quarterly capital expenditures is $2.47 million, with the most recent change of -$922.00 thousand (-27.18%) on November 24, 2024.
- Over the past year, LFCR quarterly CAPEX has dropped by -$3.50 million (-58.62%).
- LFCR quarterly CAPEX is now -83.03% below its all-time high of $14.56 million, reached on February 1, 2019.
Performance
LFCR Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CAPEX
$14.47 M
-$1.79 M-11.02%
November 24, 2024
Summary
- As of February 12, 2025, LFCR TTM capital expenditures is $14.47 million, with the most recent change of -$1.79 million (-11.02%) on November 24, 2024.
- Over the past year, LFCR TTM CAPEX has dropped by -$7.99 million (-35.57%).
- LFCR TTM CAPEX is now -68.55% below its all-time high of $46.00 million, reached on February 1, 2019.
Performance
LFCR TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
LFCR CAPEX Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -16.6% | -58.6% | -35.6% |
| 3 y3 years | -28.9% | -58.6% | -35.6% |
| 5 y5 years | -59.9% | -59.2% | -57.1% |
LFCR CAPEX Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -40.1% | at low | -78.3% | at low | -55.3% | at low |
| 5 y | 5-year | -59.9% | at low | -82.2% | at low | -57.1% | at low |
| alltime | all time | -59.9% | +4380.3% | -83.0% | +146.8% | -68.5% | +979.0% |
Lifecore Biomedical CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Nov 2024 | - | $2.47 M(-27.2%) | $14.47 M(-11.0%) |
| Aug 2024 | - | $3.39 M(+28.6%) | $16.26 M(-9.3%) |
| May 2024 | $17.92 M(-16.6%) | $2.64 M(-55.8%) | $17.92 M(-20.2%) |
| Feb 2024 | - | $5.97 M(+40.1%) | $22.46 M(-4.8%) |
| Nov 2023 | - | $4.26 M(-15.7%) | $23.59 M(+1.8%) |
| Aug 2023 | - | $5.05 M(-29.5%) | $23.18 M(+7.9%) |
| May 2023 | $21.48 M(-28.2%) | $7.17 M(+1.0%) | $21.48 M(-16.4%) |
| Feb 2023 | - | $7.10 M(+84.5%) | $25.71 M(+6.5%) |
| Nov 2022 | - | $3.85 M(+14.5%) | $24.14 M(-4.9%) |
| Aug 2022 | - | $3.36 M(-70.5%) | $25.39 M(-15.2%) |
| May 2022 | $29.94 M(+18.7%) | $11.40 M(+106.2%) | $29.94 M(-7.5%) |
| Feb 2022 | - | $5.53 M(+8.5%) | $32.38 M(+5.0%) |
| Nov 2021 | - | $5.10 M(-35.6%) | $30.83 M(+8.1%) |
| Aug 2021 | - | $7.91 M(-42.8%) | $28.51 M(+13.0%) |
| May 2021 | $25.22 M(-5.5%) | - | - |
| May 2021 | - | $13.84 M(+248.1%) | $25.22 M(+58.1%) |
| Feb 2021 | - | $3.98 M(+42.8%) | $15.95 M(-11.7%) |
| Nov 2020 | - | $2.78 M(-39.8%) | $18.06 M(-15.3%) |
| Aug 2020 | - | $4.62 M(+1.2%) | $21.33 M(-20.1%) |
| May 2020 | $26.69 M(-40.3%) | $4.57 M(-25.0%) | $26.69 M(-20.8%) |
| Feb 2020 | - | $6.09 M(+0.7%) | $33.71 M(-20.1%) |
| Nov 2019 | - | $6.05 M(-39.4%) | $42.17 M(+4.7%) |
| Aug 2019 | - | $9.98 M(-13.9%) | $40.27 M(-10.0%) |
| May 2019 | $44.73 M(+33.2%) | $11.59 M(-20.4%) | $44.73 M(-2.8%) |
| Feb 2019 | - | $14.56 M(+250.9%) | $46.00 M(+7.6%) |
| Nov 2018 | - | $4.15 M(-71.3%) | $42.74 M(+1.0%) |
| Aug 2018 | - | $14.44 M(+12.3%) | $42.30 M(+25.9%) |
| May 2018 | $33.59 M(+46.0%) | $12.86 M(+13.8%) | $33.59 M(-1.9%) |
| Feb 2018 | - | $11.30 M(+204.5%) | $34.25 M(+23.6%) |
| Nov 2017 | - | $3.71 M(-35.2%) | $27.70 M(+4.1%) |
| Aug 2017 | - | $5.73 M(-57.6%) | $26.60 M(+15.6%) |
| May 2017 | $23.00 M(-42.1%) | $13.52 M(+184.5%) | $23.00 M(-0.1%) |
| Feb 2017 | - | $4.75 M(+82.2%) | $23.02 M(-21.2%) |
| Nov 2016 | - | $2.61 M(+22.3%) | $29.23 M(-23.8%) |
| Aug 2016 | - | $2.13 M(-84.3%) | $38.34 M(-3.4%) |
| May 2016 | $39.70 M(+126.7%) | $13.54 M(+23.5%) | $39.70 M(+18.6%) |
| Feb 2016 | - | $10.96 M(-6.5%) | $33.47 M(+30.8%) |
| Nov 2015 | - | $11.72 M(+236.0%) | $25.58 M(+51.4%) |
| Aug 2015 | - | $3.49 M(-52.3%) | $16.90 M(-3.5%) |
| May 2015 | $17.51 M(+17.6%) | $7.31 M(+138.3%) | $17.51 M(+17.6%) |
| Feb 2015 | - | $3.07 M(+1.0%) | $14.90 M(+3.9%) |
| Nov 2014 | - | $3.04 M(-25.9%) | $14.34 M(-2.0%) |
| Aug 2014 | - | $4.10 M(-12.7%) | $14.64 M(-1.7%) |
| May 2014 | $14.89 M(+67.7%) | $4.69 M(+86.9%) | $14.89 M(+2.4%) |
| Feb 2014 | - | $2.51 M(-24.7%) | $14.53 M(+9.4%) |
| Nov 2013 | - | $3.34 M(-23.2%) | $13.28 M(+18.6%) |
| Aug 2013 | - | $4.34 M(+0.1%) | $11.19 M(+26.1%) |
| May 2013 | $8.88 M(+65.3%) | $4.34 M(+244.9%) | $8.88 M(+47.5%) |
| Feb 2013 | - | $1.26 M(+0.6%) | $6.02 M(+7.3%) |
| Nov 2012 | - | $1.25 M(-38.3%) | $5.61 M(-3.9%) |
| Aug 2012 | - | $2.03 M(+37.2%) | $5.84 M(+8.7%) |
| May 2012 | $5.37 M(-19.6%) | $1.48 M(+74.0%) | $5.37 M(-5.8%) |
| Feb 2012 | - | $850.00 K(-42.6%) | $5.70 M(-9.2%) |
| Nov 2011 | - | $1.48 M(-5.1%) | $6.28 M(-4.5%) |
| Aug 2011 | - | $1.56 M(-13.7%) | $6.57 M(-1.7%) |
| May 2011 | $6.68 M | $1.81 M(+26.9%) | $6.68 M(+5.7%) |
| Feb 2011 | - | $1.43 M(-19.7%) | $6.32 M(+15.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Nov 2010 | - | $1.77 M(+5.8%) | $5.48 M(-0.7%) |
| Aug 2010 | - | $1.68 M(+15.8%) | $5.52 M(+6.4%) |
| May 2010 | $5.19 M(+13.5%) | $1.45 M(+146.9%) | $5.19 M(+1.5%) |
| Feb 2010 | - | $586.00 K(-67.7%) | $5.12 M(-4.2%) |
| Nov 2009 | - | $1.81 M(+35.0%) | $5.34 M(+5.9%) |
| Aug 2009 | - | $1.34 M(-2.0%) | $5.05 M(+10.3%) |
| May 2009 | $4.58 M(+7.9%) | $1.37 M(+69.0%) | $4.58 M(-9.9%) |
| Feb 2009 | - | $812.00 K(-46.5%) | $5.08 M(-1.8%) |
| Nov 2008 | - | $1.52 M(+73.7%) | $5.17 M(+6.1%) |
| Aug 2008 | - | $874.00 K(-53.4%) | $4.88 M(+15.0%) |
| May 2008 | $4.24 M(-37.5%) | $1.88 M(+107.1%) | $4.24 M(+32.8%) |
| Feb 2008 | - | $906.00 K(-25.9%) | $3.19 M(-11.0%) |
| Nov 2007 | - | $1.22 M(+417.8%) | $3.59 M(-23.2%) |
| Aug 2007 | - | $236.00 K(-71.5%) | $4.68 M(-31.1%) |
| May 2007 | $6.78 M(+42.9%) | $829.00 K(-36.3%) | $6.78 M(+44.0%) |
| Feb 2007 | - | $1.30 M(-43.6%) | $4.71 M(-40.1%) |
| Nov 2006 | - | $2.31 M(-1.4%) | $7.86 M(+21.8%) |
| Aug 2006 | - | $2.34 M(-288.4%) | $6.46 M(+36.0%) |
| May 2006 | $4.75 M(+29.7%) | -$1.24 M(-127.9%) | $4.75 M(-28.1%) |
| Feb 2006 | - | $4.46 M(+395.1%) | $6.60 M(+112.7%) |
| Nov 2005 | - | $900.00 K(+42.2%) | $3.10 M(-8.8%) |
| Aug 2005 | - | $633.00 K(+4.1%) | $3.40 M(-7.0%) |
| May 2005 | $3.66 M(+7.8%) | $608.00 K(-36.7%) | $3.66 M(-0.2%) |
| Feb 2005 | - | $961.00 K(-19.9%) | $3.67 M(-3.1%) |
| Nov 2004 | - | $1.20 M(+35.0%) | $3.78 M(+5.3%) |
| Aug 2004 | - | $889.00 K(+44.1%) | $3.59 M(+5.9%) |
| May 2004 | $3.39 M(+174.5%) | $617.00 K(-42.7%) | $3.39 M(+9.9%) |
| Feb 2004 | - | $1.08 M(+6.6%) | $3.09 M(+9.5%) |
| Nov 2003 | - | $1.01 M(+46.6%) | $2.82 M(+17.4%) |
| Aug 2003 | - | $689.00 K(+122.3%) | $2.40 M(+15.4%) |
| May 2003 | $1.24 M(-51.5%) | - | - |
| Apr 2003 | - | $310.00 K(-61.6%) | $2.08 M(+0.5%) |
| Jan 2003 | - | $808.00 K(+36.5%) | $2.07 M(-18.7%) |
| Oct 2002 | $2.55 M(-63.4%) | $592.00 K(+60.4%) | $2.55 M(-35.5%) |
| Jul 2002 | - | $369.00 K(+23.0%) | $3.94 M(+1.4%) |
| Apr 2002 | - | $300.00 K(-76.7%) | $3.89 M(-41.8%) |
| Jan 2002 | - | $1.28 M(-35.5%) | $6.68 M(-4.1%) |
| Oct 2001 | $6.96 M(+83.8%) | $1.99 M(+536.1%) | $6.96 M(+26.6%) |
| Jul 2001 | - | $313.00 K(-89.9%) | $5.50 M(-18.2%) |
| Apr 2001 | - | $3.09 M(+97.2%) | $6.72 M(-508.1%) |
| Jan 2001 | - | $1.57 M(+197.3%) | -$1.65 M(-143.5%) |
| Oct 2000 | $3.79 M(+282.5%) | $527.00 K(-65.6%) | $3.79 M(+180.5%) |
| Jul 2000 | - | $1.53 M(-129.1%) | $1.35 M(+20.9%) |
| Apr 2000 | - | -$5.27 M(-175.3%) | $1.12 M(-84.5%) |
| Jan 2000 | - | $7.00 M(-466.5%) | $7.19 M(+626.3%) |
| Oct 1999 | $990.00 K(-78.0%) | -$1.91 M(-246.9%) | $990.00 K(-76.4%) |
| Jul 1999 | - | $1.30 M(+62.5%) | $4.20 M(-14.3%) |
| Apr 1999 | - | $800.00 K(0.0%) | $4.90 M(0.0%) |
| Jan 1999 | - | $800.00 K(-38.5%) | $4.90 M(+8.9%) |
| Oct 1998 | $4.50 M(+246.2%) | $1.30 M(-35.0%) | $4.50 M(+28.6%) |
| Jul 1998 | - | $2.00 M(+150.0%) | $3.50 M(+94.4%) |
| Apr 1998 | - | $800.00 K(+100.0%) | $1.80 M(+38.5%) |
| Jan 1998 | - | $400.00 K(+33.3%) | $1.30 M(0.0%) |
| Oct 1997 | $1.30 M(+225.0%) | $300.00 K(0.0%) | $1.30 M(+30.0%) |
| Jul 1997 | - | $300.00 K(0.0%) | $1.00 M(+42.9%) |
| Apr 1997 | - | $300.00 K(-25.0%) | $700.00 K(+75.0%) |
| Jan 1997 | - | $400.00 K | $400.00 K |
| Oct 1996 | $400.00 K | - | - |
FAQ
- What is Lifecore Biomedical annual capital expenditures?
- What is the all time high annual CAPEX for Lifecore Biomedical?
- What is Lifecore Biomedical annual CAPEX year-on-year change?
- What is Lifecore Biomedical quarterly capital expenditures?
- What is the all time high quarterly CAPEX for Lifecore Biomedical?
- What is Lifecore Biomedical quarterly CAPEX year-on-year change?
- What is Lifecore Biomedical TTM capital expenditures?
- What is the all time high TTM CAPEX for Lifecore Biomedical?
- What is Lifecore Biomedical TTM CAPEX year-on-year change?
What is Lifecore Biomedical annual capital expenditures?
The current annual CAPEX of LFCR is $17.92 M
What is the all time high annual CAPEX for Lifecore Biomedical?
Lifecore Biomedical all-time high annual capital expenditures is $44.73 M
What is Lifecore Biomedical annual CAPEX year-on-year change?
Over the past year, LFCR annual capital expenditures has changed by -$3.56 M (-16.58%)
What is Lifecore Biomedical quarterly capital expenditures?
The current quarterly CAPEX of LFCR is $2.47 M
What is the all time high quarterly CAPEX for Lifecore Biomedical?
Lifecore Biomedical all-time high quarterly capital expenditures is $14.56 M
What is Lifecore Biomedical quarterly CAPEX year-on-year change?
Over the past year, LFCR quarterly capital expenditures has changed by -$3.50 M (-58.62%)
What is Lifecore Biomedical TTM capital expenditures?
The current TTM CAPEX of LFCR is $14.47 M
What is the all time high TTM CAPEX for Lifecore Biomedical?
Lifecore Biomedical all-time high TTM capital expenditures is $46.00 M
What is Lifecore Biomedical TTM CAPEX year-on-year change?
Over the past year, LFCR TTM capital expenditures has changed by -$7.99 M (-35.57%)